Updated Functional Classification of β-Lactamases

被引:1565
作者
Bush, Karen [1 ]
Jacoby, George A. [2 ]
机构
[1] Indiana Univ, Dept Biol, Bloomington, IN 47401 USA
[2] Lahey Clin Fdn, Burlington, MA USA
关键词
STANDARD NUMBERING SCHEME; EXTENDED-SPECTRUM CEPHALOSPORINASES; OXACILLINASE-MEDIATED RESISTANCE; KLEBSIELLA-PNEUMONIAE ISOLATE; VIBRIO-CHOLERAE NON-O1; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; NUCLEOTIDE-SEQUENCE; REDUCED SUSCEPTIBILITY;
D O I
10.1128/AAC.01009-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Two classification schemes for beta-lactamases are currently in use. The molecular classification is based on the amino acid sequence and divides beta-lactamases into class A, C, and D enzymes which utilize serine for beta-lactam hydrolysis and class B metalloenzymes which require divalent zinc ions for substrate hydrolysis. The functional classification scheme updated herein is based on the 1995 proposal by Bush et al. (K. Bush, G. A. Jacoby, and A. A. Medeiros, Antimicrob. Agents Chemother. 39: 1211-1233, 1995). It takes into account substrate and inhibitor profiles in an attempt to group the enzymes in ways that can be correlated with their phenotype in clinical isolates. Major groupings generally correlate with the more broadly based molecular classification. The updated system includes group 1 (class C) cephalosporinases; group 2 (classes A and D) broad-spectrum, inhibitor-resistant, and extended-spectrum beta-lactamases and serine carbapenemases; and group 3 metallo-beta-lactamases. Several new subgroups of each of the major groups are described, based on specific attributes of individual enzymes. A list of attributes is also suggested for the description of a new beta-lactamase, including the requisite microbiological properties, substrate and inhibitor profiles, and molecular sequence data that provide an adequate characterization for a new beta-lactam-hydrolyzing enzyme.
引用
收藏
页码:969 / 976
页数:8
相关论文
共 74 条
[1]   Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC β-lactamase, CMY-37 [J].
Ahmed, Ashraf M. ;
Shimamoto, Tadashi .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (03) :256-261
[3]   A STANDARD NUMBERING SCHEME FOR THE CLASS-A BETA-LACTAMASES [J].
AMBLER, RP ;
COULSON, AFW ;
FRERE, JM ;
GHUYSEN, JM ;
JORIS, B ;
FORSMAN, M ;
LEVESQUE, RC ;
TIRABY, G ;
WALEY, SG .
BIOCHEMICAL JOURNAL, 1991, 276 :269-270
[4]  
[Anonymous], 2009, M100S19 CLIN LAB STA
[5]   Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa [J].
Aubert, D ;
Poirel, L ;
Chevalier, J ;
Leotard, S ;
Pages, JM ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1615-1620
[6]   Unusual tazobactam-sensitive AmpC β-lactamase from two Escherichia coli isolates [J].
Babini, GS ;
Danel, F ;
Munro, SD ;
Micklesen, PA ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :115-118
[7]   A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia [J].
Bauernfeind, A ;
Schneider, I ;
Jungwirth, R ;
Sahly, H ;
Ullmann, U .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1924-1931
[8]   Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum [J].
Bellais, S ;
Aubert, D ;
Naas, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1878-1886
[9]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[10]   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City [J].
Bradford, PA ;
Bratu, S ;
Urban, C ;
Visalli, M ;
Mariano, N ;
Landman, D ;
Rahal, JJ ;
Brooks, S ;
Cebular, S ;
Quale, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :55-60